JCO-话题@MedSci

#JCO#

724篇内容 | 6876人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1891214, encodeId=d37c189121439, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：曲妥单抗增加心脏病风险, objectType=article, longId=56525, objectId=0fc55652546, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0fc55652546, replyNumber=0, likeNumber=85, createdTime=2016-08-11, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0fc55652546, moduleTitle=JCO：曲妥单抗增加心脏病风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0fc55652546)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891239, encodeId=22c1189123977, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：HER2阳性乳腺癌化疗——拉帕替尼并不优于曲妥单抗，反而增加了药毒性, objectType=article, longId=60124, objectId=d131601246f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d131601246f, replyNumber=0, likeNumber=75, createdTime=2016-01-02, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d131601246f, moduleTitle=JCO：HER2阳性乳腺癌化疗——拉帕替尼并不优于曲妥单抗，反而增加了药毒性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d131601246f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891275, encodeId=e5dd18912e5bc, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：成人发病癌症存活者的心血管疾病风险, objectType=article, longId=70856, objectId=1bace0856e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1bace0856e9, replyNumber=0, likeNumber=67, createdTime=2016-08-14, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1bace0856e9, moduleTitle=JCO：成人发病癌症存活者的心血管疾病风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1bace0856e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891217, encodeId=068f189121e00, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO:视网膜细胞瘤患者心理健康研究, objectType=article, longId=56797, objectId=c04356e973f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c04356e973f, replyNumber=0, likeNumber=68, createdTime=2015-10-16, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c04356e973f, moduleTitle=JCO:视网膜细胞瘤患者心理健康研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c04356e973f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891229, encodeId=54821891229ef, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：霍奇金淋巴瘤幸存者的放疗剂量-反应关系可用于预测冠心病风险, objectType=article, longId=58972, objectId=60b4589e29d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=60b4589e29d, replyNumber=0, likeNumber=67, createdTime=2016-09-23, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=60b4589e29d, moduleTitle=JCO：霍奇金淋巴瘤幸存者的放疗剂量-反应关系可用于预测冠心病风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=60b4589e29d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891222, encodeId=0d22189122264, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：地磷莫司治疗晚期子宫内膜癌是有效的，但毒副作用太大, objectType=article, longId=58171, objectId=6785581e140, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6785581e140, replyNumber=0, likeNumber=64, createdTime=2016-09-23, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6785581e140, moduleTitle=JCO：地磷莫司治疗晚期子宫内膜癌是有效的，但毒副作用太大, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6785581e140)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891243, encodeId=f566189124319, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：癌症中度疼痛使用低剂量吗啡镇痛，效果显著！, objectType=article, longId=60523, objectId=a47960523af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a47960523af, replyNumber=0, likeNumber=58, createdTime=2016-06-09, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a47960523af, moduleTitle=JCO：癌症中度疼痛使用低剂量吗啡镇痛，效果显著！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a47960523af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891265, encodeId=7bc8189126504, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：卵巢癌新药Farletuzumab三期临床试验结果发表，3年前已完成试验，结果阴性, objectType=article, longId=65679, objectId=6781656e9f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6781656e9f0, replyNumber=0, likeNumber=83, createdTime=2017-03-11, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6781656e9f0, moduleTitle=JCO：卵巢癌新药Farletuzumab三期临床试验结果发表，3年前已完成试验，结果阴性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6781656e9f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891262, encodeId=2832189126247, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：博来霉素、依托泊苷、顺铂的肺损伤影响有限, objectType=article, longId=63891, objectId=43346389176, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=43346389176, replyNumber=0, likeNumber=0, createdTime=2016-05-31, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=43346389176, moduleTitle=JCO：博来霉素、依托泊苷、顺铂的肺损伤影响有限, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=43346389176)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891256, encodeId=a5ba189125622, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：埃罗替尼、质子泵抑制剂同服，理想再来点可乐, objectType=article, longId=63123, objectId=621163123f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=621163123f0, replyNumber=0, likeNumber=96, createdTime=2016-03-04, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=621163123f0, moduleTitle=JCO：埃罗替尼、质子泵抑制剂同服，理想再来点可乐, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=621163123f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891212, encodeId=463718912120f, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：阿司匹林可预防结直肠癌发病风险, objectType=article, longId=55264, objectId=27505526416, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=27505526416, replyNumber=0, likeNumber=81, createdTime=2016-02-29, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=27505526416, moduleTitle=JCO：阿司匹林可预防结直肠癌发病风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=27505526416)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891208, encodeId=931718912088b, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：服用阿司匹林可降低肥胖Lynch综合征（结直肠癌）病人患癌风险, objectType=article, longId=55037, objectId=70495503ea4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=70495503ea4, replyNumber=0, likeNumber=80, createdTime=2016-02-07, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=70495503ea4, moduleTitle=JCO：服用阿司匹林可降低肥胖Lynch综合征（结直肠癌）病人患癌风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=70495503ea4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891219, encodeId=fb37189121924, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：医生应该告知晚期癌症患者的预后吗？, objectType=article, longId=57076, objectId=cf795e0762b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf795e0762b, replyNumber=0, likeNumber=98, createdTime=2015-10-23, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf795e0762b, moduleTitle=JCO：医生应该告知晚期癌症患者的预后吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cf795e0762b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891270, encodeId=a55418912e0c0, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：他莫昔芬加卵巢功能抑制治疗能更好控制乳腺癌, objectType=article, longId=65869, objectId=08d965869ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=08d965869ad, replyNumber=0, likeNumber=76, createdTime=2016-12-21, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=08d965869ad, moduleTitle=JCO：他莫昔芬加卵巢功能抑制治疗能更好控制乳腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=08d965869ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891199, encodeId=43921891199fc, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：早期拉帕替尼联用曲妥单抗对HER2+乳腺癌效果更优, objectType=article, longId=53352, objectId=0f17533529c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f17533529c, replyNumber=0, likeNumber=90, createdTime=2015-08-02, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f17533529c, moduleTitle=JCO：早期拉帕替尼联用曲妥单抗对HER2+乳腺癌效果更优, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f17533529c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891196, encodeId=952f189119613, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：姑息治疗越早，节省越多, objectType=article, longId=52060, objectId=ede452060e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ede452060e7, replyNumber=0, likeNumber=89, createdTime=2016-05-23, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ede452060e7, moduleTitle=JCO：姑息治疗越早，节省越多, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ede452060e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891218, encodeId=b6ae189121810, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：奥拉帕尼联用紫杉醇治疗胃癌增加总生存率, objectType=article, longId=57068, objectId=ffcc5e06861, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ffcc5e06861, replyNumber=0, likeNumber=77, createdTime=2016-04-20, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ffcc5e06861, moduleTitle=JCO：奥拉帕尼联用紫杉醇治疗胃癌增加总生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ffcc5e06861)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891249, encodeId=d2251891249f3, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：肿瘤淋巴细胞浸润可以作为预后标志物, objectType=article, longId=63098, objectId=b602630980d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b602630980d, replyNumber=0, likeNumber=74, createdTime=2016-02-23, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b602630980d, moduleTitle=JCO：肿瘤淋巴细胞浸润可以作为预后标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b602630980d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891187, encodeId=e12a189118e61, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO:吸烟增加结直肠癌的死亡率, objectType=article, longId=50269, objectId=baa7502697e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=baa7502697e, replyNumber=0, likeNumber=118, createdTime=2016-03-08, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=baa7502697e, moduleTitle=JCO:吸烟增加结直肠癌的死亡率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=baa7502697e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891211, encodeId=f2e81891211b9, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：又一早期肺癌生物学标志物---diacetylspermine被发现, objectType=article, longId=55107, objectId=8d4e5510ef0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8d4e5510ef0, replyNumber=0, likeNumber=58, createdTime=2015-11-05, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8d4e5510ef0, moduleTitle=JCO：又一早期肺癌生物学标志物---diacetylspermine被发现, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8d4e5510ef0)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

JCO

2020-05-29

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：曲妥单抗增加心脏病风险

2016-08-11

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：HER2阳性乳腺癌化疗——拉帕替尼并不优于曲妥单抗，反而增加了药毒性

2016-01-02

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：成人发病癌症存活者的心血管疾病风险

2016-08-14

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO:视网膜细胞瘤患者心理健康研究

2015-10-16

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：霍奇金淋巴瘤幸存者的放疗剂量-反应关系可用于预测冠心病风险

2016-09-23

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：地磷莫司治疗晚期子宫内膜癌是有效的，但毒副作用太大

2016-09-23

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：癌症中度疼痛使用低剂量吗啡镇痛，效果显著！

2016-06-09

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：卵巢癌新药Farletuzumab三期临床试验结果发表，3年前已完成试验，结果阴性

2017-03-11

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：博来霉素、依托泊苷、顺铂的肺损伤影响有限

2016-05-31

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：埃罗替尼、质子泵抑制剂同服，理想再来点可乐

2016-03-04

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：阿司匹林可预防结直肠癌发病风险

2016-02-29

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：服用阿司匹林可降低肥胖Lynch综合征（结直肠癌）病人患癌风险

2016-02-07

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：医生应该告知晚期癌症患者的预后吗？

2015-10-23

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：他莫昔芬加卵巢功能抑制治疗能更好控制乳腺癌

2016-12-21

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：早期拉帕替尼联用曲妥单抗对HER2+乳腺癌效果更优

2015-08-02

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：姑息治疗越早，节省越多

2016-05-23

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：奥拉帕尼联用紫杉醇治疗胃癌增加总生存率

2016-04-20

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：肿瘤淋巴细胞浸润可以作为预后标志物

2016-02-23

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO:吸烟增加结直肠癌的死亡率

2016-03-08

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：又一早期肺癌生物学标志物---diacetylspermine被发现

2015-11-05

科室
- - 订阅+
  - 更多科室
工具
服务